Internal Medicine, Cardiovascular Disease · Brooklyn, NY
NPI
1225252828
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
506 6th St, NY Methodist Hospital/Division of Cardiology
Brooklyn, NY, 11215
Phone (718) 780-5664
Groups this clinician bills Medicare through
Medicare paid, 2024
$425K
5,926 services
Medicare patients, 2024
1,840
Average age 77
Drug cost, 2024
$5.0M
9,120 prescriptions
Company payments, 2025
$646
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hajir E Dilmanian was code 93306 (echocardiography (tte/tee)), 1,317 times for 1,194 patients. In total Hajir E Dilmanian billed 5,926 services in 42 codes, and Medicare paid $425K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93306 Echocardiography (TTE/TEE) | Facility | 1,317 | 1,194 | $56.19 | $74K |
| 99232 Hospital E&M - Subsequent | Facility | 996 | 167 | $70.92 | $71K |
| 99233 Hospital E&M - Subsequent | Facility | 463 | 174 | $106.23 | $49K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 352 | 153 | $14.24 | $5,012 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 324 | 164 | $13.88 | $4,496 |
| 99214 Office E&M - Established | Facility | 213 | 116 | $78.99 | $17K |
| 93010 Electrocardiogram | Facility | 206 | 127 | $6.59 | $1,357 |
| 99223 Hospital E&M - Initial | Facility | 198 | 163 | $152.90 | $30K |
| 99214 Office E&M - Established | Office | 195 | 116 | $105.16 | $21K |
| 99215 Office E&M - Established | Office | 155 | 72 | $157.39 | $24K |
| 93306 Echocardiography (TTE/TEE) | Office | 129 | 129 | $146.82 | $19K |
| 99291 Critical Care E&M | Facility | 129 | 62 | $193.00 | $25K |
| 93018 Electrocardiogram | Facility | 122 | 122 | $11.60 | $1,415 |
| 93016 Electrocardiogram | Facility | 121 | 121 | $17.43 | $2,110 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 105 | 104 | $174.24 | $18K |
By year: 2022 $396K for 4,681 services; 2023 $438K for 5,036 services; 2024 $425K for 5,926 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 30 | 23 | $8.65 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug Hajir E Dilmanian prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,094 prescriptions and refills. In total Hajir E Dilmanian wrote 9,120 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,094 | 3,079 | 351 | $18K |
| Mounjaro Tirzepatide | 521 | 587 | 96 | $608K |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 488 | 1,412 | 177 | $7,608 |
| Ozempic Semaglutide | 478 | 689 | 116 | $650K |
| Atorvastatin Calcium Generic | 442 | 1,218 | 165 | $4,910 |
| Metoprolol Succinate Generic | 418 | 1,028 | 176 | $9,254 |
| Carvedilol Generic | 336 | 950 | 128 | $3,195 |
| Carvedilol Er Carvedilol Phosphate | 332 | 787 | 101 | $120K |
| Farxiga Dapagliflozin Propanediol | 325 | 726 | 102 | $380K |
| Eliquis Apixaban | 314 | 645 | 91 | $370K |
| Ramipril Generic | 280 | 801 | 103 | $2,846 |
| Olmesartan-Amlodipine-Hctz Olmesartan/Amlodipin/Hcthiazid | 254 | 641 | 99 | $23K |
| Trulicity Dulaglutide | 246 | 326 | 65 | $307K |
| Xarelto Rivaroxaban | 217 | 430 | 54 | $234K |
| Rybelsus Semaglutide | 178 | 407 | 62 | $374K |
Brand drugs: - claims; generic drugs: 6,086 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hajir E Dilmanian $646 ($646 in general payments such as food, travel and fees) from 4 companies. The largest payer was Kestra Medical Technology Services, Inc. with $297.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.